Literature DB >> 20154210

Essential role of mitochondrial antiviral signaling, IFN regulatory factor (IRF)3, and IRF7 in Chlamydophila pneumoniae-mediated IFN-beta response and control of bacterial replication in human endothelial cells.

Claudia Buss1, Bastian Opitz, Andreas C Hocke, Juliane Lippmann, Vincent van Laak, Stefan Hippenstiel, Matthias Krüll, Norbert Suttorp, Julia Eitel.   

Abstract

Chlamydophila pneumoniae infection of the vascular wall as well as activation of the transcription factor IFN regulatory factor (IRF)3 have been linked to development of chronic vascular lesions and atherosclerosis. The innate immune system detects invading pathogens by use of pattern recognition receptors, some of which are able to stimulate IRF3/7 activation and subsequent type I IFN production (e. g., IFN-beta). In this study, we show that infection of human endothelial cells with C. pneumoniae-induced production of IFN-beta, a cytokine that so far has been mainly associated with antiviral immunity. Moreover, C. pneumoniae infection led to IRF3 and IRF7 nuclear translocation in HUVECs and RNA interference experiments showed that IRF3 and IRF7 as well as the mitochondrial antiviral signaling (MAVS) were essential for IFN-beta induction. Finally, C. pneumoniae replication was enhanced in endothelial cells in which IRF3, IRF7, or MAVS expression was inhibited by small interfering RNA and attenuated by IFN-beta treatment. In conclusion, C. pneumoniae infection of endothelial cells activates an MAVS-, IRF3-, and IRF7-dependent signaling, which controls bacterial growth and might modulate development of vascular lesions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20154210     DOI: 10.4049/jimmunol.0902947

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  25 in total

1.  Significant role of IL-1 signaling, but limited role of inflammasome activation, in oviduct pathology during Chlamydia muridarum genital infection.

Authors:  Uma M Nagarajan; James D Sikes; Laxmi Yeruva; Daniel Prantner
Journal:  J Immunol       Date:  2012-02-13       Impact factor: 5.422

2.  Dissection of a type I interferon pathway in controlling bacterial intracellular infection in mice.

Authors:  Juliane Lippmann; Holger C Müller; Jan Naujoks; Christoph Tabeling; Sunny Shin; Martin Witzenrath; Katharina Hellwig; Carsten J Kirschning; Gregory A Taylor; Winfried Barchet; Stefan Bauer; Norbert Suttorp; Craig R Roy; Bastian Opitz
Journal:  Cell Microbiol       Date:  2011-08-24       Impact factor: 3.715

3.  IRF3 Inhibits Neutrophil Recruitment in Mice Infected with Pseudomonas aeruginosa.

Authors:  Zhenghao Piao; Haiying Yuan; Cuili Wang; Liyun Shi
Journal:  Inflammation       Date:  2017-06       Impact factor: 4.092

4.  Multiple preconditioning paradigms converge on interferon regulatory factor-dependent signaling to promote tolerance to ischemic brain injury.

Authors:  Susan L Stevens; Philberta Y Leung; Keri B Vartanian; Banu Gopalan; Tao Yang; Roger P Simon; Mary P Stenzel-Poore
Journal:  J Neurosci       Date:  2011-06-08       Impact factor: 6.167

5.  Proteomic-based approach to gain insight into reprogramming of THP-1 cells exposed to Leishmania donovani over an early temporal window.

Authors:  Alok Kumar Singh; Rajeev Kumar Pandey; Jair Lage Siqueira-Neto; Yong-Jun Kwon; Lucio H Freitas-Junior; Chandrima Shaha; Rentala Madhubala
Journal:  Infect Immun       Date:  2015-02-17       Impact factor: 3.441

6.  Beta interferon-mediated activation of signal transducer and activator of transcription protein 1 interferes with Rickettsia conorii replication in human endothelial cells.

Authors:  Punsiri M Colonne; Marina E Eremeeva; Sanjeev K Sahni
Journal:  Infect Immun       Date:  2011-06-20       Impact factor: 3.441

7.  Interferon response factors 3 and 7 protect against Chikungunya virus hemorrhagic fever and shock.

Authors:  Penny A Rudd; Jane Wilson; Joy Gardner; Thibaut Larcher; Candice Babarit; Thuy T Le; Itaru Anraku; Yutaro Kumagai; Yueh-Ming Loo; Michael Gale; Shizuo Akira; Alexander A Khromykh; Andreas Suhrbier
Journal:  J Virol       Date:  2012-07-03       Impact factor: 5.103

Review 8.  Type I interferon: friend or foe?

Authors:  Giorgio Trinchieri
Journal:  J Exp Med       Date:  2010-09-13       Impact factor: 14.307

Review 9.  Toll-like receptors and damage-associated molecular patterns: novel links between inflammation and hypertension.

Authors:  Cameron G McCarthy; Styliani Goulopoulou; Camilla F Wenceslau; Kathryn Spitler; Takayuki Matsumoto; R Clinton Webb
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-10-25       Impact factor: 4.733

10.  Chlamydia pneumoniae impairs the innate immune response in infected epithelial cells by targeting TRAF3.

Authors:  Katerina Wolf; Kenneth A Fields
Journal:  J Immunol       Date:  2013-01-09       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.